Xena and others, while it might not be kosher, is it possible that Anavex may have asked to reduce number of P2b/3 participants (from 450 to 300) and, in effect, replace them with Rett (30) and PDD (120) participants? This allows the Aussies to see the strong impact of 2-73 on multiple CNS diseases.
Anavex Now ... Mono-style ... and RWEm for Life!!!
Market Data 
Markets 
AI
